Why the study?
Does Anti-ANG-(1-12) IgG reduce systolic blood pressure in male adult (mRen2)27 hypertensive rats?
Does Anti-ANG-(1-12) IgG reduce systolic blood pressure in male adult (mRen2)27 hypertensive rats?
Immunoneutralization of brain ANG-(1-12) lowers blood pressure in hypertensive rats, suggesting it is functionally active in brain pathways regulating blood pressure.
Answers are grounded in this paper and cite their sources.
Supports brain ANG-(1-12) activity in rodent hypertension; hypothesis-generating with no clinical implications yet.
Angiotensin-(1-12) [ANG-(1-12)] is a newly identified peptide detected in a variety of rat tissues, including the brain. To determine whether brain ANG-(1-12) participates in blood pressure regulation, we treated male adult (mRen2)27 hypertensive rats (24-28 wk of age) with Anti-ANG-(1-12) IgG or Preimmune IgG via an intracerebroventricular cannula for 14 days. Immunoneutralization of brain ANG-(1-12) lowered systolic blood pressure (-43 +/- 8 mmHg on day 3 and -26 +/- 7 mmHg on day 10 from baseline, P < 0.05). Water intake was lower on intracereroventricular day 6 in the Anti-ANG-(1-12) IgG group, accompanied by higher plasma osmolality on day 13, but there were no differences in urine volume, food intake, or body weight during the 2-wk treatment. In Preimmune IgG-treated animals, there were no significant changes in these variables over the 2-wk period. The antihypertensive effects produced by endogenous neutralization of brain ANG-(1-12) suggest that ANG-(1-12) is functionally active in brain pathways regulating blood pressure.
No takes yet. Share an insight, caveat, or question.
Isa et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: